Cipla and other pharma companies to have good times: P Phani Sekhar

In a chat with ET Now, P Phani Sekhar, Fund Manager-PMS, Angel Broking, shares his views on Cipla.

ET Now: What is your call on Cipla?

P Phani Sekhar: Well, the stock also rallied very sharply in the matter of three-four months. It almost got rerated both on the back of revival in its domestic business and also on how well it can do globally.

With some disappointment in the domestic business, although the decline seems a little excessive, but I guess that the rerating in Cipla is here to continue till you see at least two quarters of more disappointment. So believers in Cipla can actually use this opportunity to accumulate the stock more, because I guess good times for Cipla and the larger pharma pack here to continue for at least another four to six quarters.